help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0266
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burd, C. J.
Right arrow Articles by Knudsen, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burd, C. J.
Right arrow Articles by Knudsen, K. E.
Molecular Endocrinology 19 (3): 607-620
Copyright © 2005 by The Endocrine Society

Cyclin D1 Binding to the Androgen Receptor (AR) NH2-Terminal Domain Inhibits Activation Function 2 Association and Reveals Dual Roles for AR Corepression

C. J. Burd, C. E. Petre, H. Moghadam, E. M. Wilson and K. E. Knudsen

Department of Cell Biology (C.J.B., C.E.P., H.M., K.E.K.) and Center for Environmental Genetics (K.E.K.), University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0521; and Laboratories of Reproductive Biology (E.M.W.) and the Department of Pediatrics and Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599-7500

Address all correspondence and requests for reprints to: Karen E. Knudsen, Department of Cell Biology, University of Cincinnati College of Medicine, P.O. Box 670521, 3125 Eden Avenue, Cincinnati, Ohio 45267-0521. E-mail: Karen.Knudsen{at}uc.edu.

The androgen receptor (AR) is a member of the nuclear receptor superfamily, the activity of which is critical for the development and progression of prostate cancer. We and others have previously demonstrated that cyclin D1 is a potent corepressor of the AR. Although cyclin D1 is suspected to recruit histone deacetylases to the AR complex, previous studies have demonstrated that this activity alone is insufficient for cyclin D1 function. Here, we uncover a novel, secondary means of cyclin D1-mediated repression, through modulation of AR amino-carboxy terminal interactions. We show that cyclin D1 predominantly binds the N-terminal domain of the AR, dependent on the AR 23FxxLF27 motif. Through this motif, cyclin D1 abrogates the ability of the AR N-terminal domain to interact with the C terminus. Secondary amino-terminal domain sites capable of fostering interaction with the C terminus were refractory to cyclin D1 action, indicating that the ability of cyclin D1 to modulate AR amino-carboxy terminal interactions is specific to 23FxxLF27. Deletion of the N-terminal cyclin D1 binding site severely compromised AR activity (due to loss of FxxLF) but unmasked a repressor action through interaction with the AR C terminus. In summary, these data reveal novel, unexpected mechanisms of cyclin D1 activity and demonstrate that this function of cyclin D1 is critical for AR modulation.

NURSA Molecule Pages Link:

Nuclear Receptors:   AR
Coregulators:   p53  |  Cyclin D1  |  GRIP1
Ligands:   Dihydrotestosterone



This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
G. E Dressing, C. R Hagan, T. P Knutson, A. R Daniel, and C. A Lange
Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models
Endocr. Relat. Cancer, June 1, 2009; 16(2): 351 - 361.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. F. Need, H. I. Scher, A. A. Peters, N. L. Moore, A. Cheong, C. J. Ryan, G. A. Wittert, V. R. Marshall, W. D. Tilley, and G. Buchanan
A Novel Androgen Receptor Amino Terminal Region Reveals Two Classes of Amino/Carboxyl Interaction-Deficient Variants with Divergent Capacity to Activate Responsive Sites in Chromatin
Endocrinology, June 1, 2009; 150(6): 2674 - 2682.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. E. Rosenblatt and K. L. Burnstein
Inhibition of Androgen Receptor Transcriptional Activity as a Novel Mechanism of Action of Arsenic
Mol. Endocrinol., March 1, 2009; 23(3): 412 - 421.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. M. Centenera, J. M. Harris, W. D. Tilley, and L. M. Butler
Minireview: The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and Signaling
Mol. Endocrinol., November 1, 2008; 22(11): 2373 - 2382.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. V. Heemers and D. J. Tindall
Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex
Endocr. Rev., December 1, 2007; 28(7): 778 - 808.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Zong, Y. Chi, Y. Wang, Y. Yang, L. Zhang, H. Chen, J. Jiang, Z. Li, Y. Hong, H. Wang, et al.
Cyclin D3/CDK11p58 Complex Is Involved in the Repression of Androgen Receptor
Mol. Cell. Biol., October 15, 2007; 27(20): 7125 - 7142.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
X. Huang, B. Jiao, C. K. Fung, Y. Zhang, W. K K Ho, C. B. Chan, H. Lin, D. Wang, and C. H K Cheng
The presence of two distinct prolactin receptors in seabream with different tissue distribution patterns, signal transduction pathways and regulation of gene expression by steroid hormones
J. Endocrinol., August 1, 2007; 194(2): 373 - 392.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C. J Burd, L. M Morey, and K. E Knudsen
Androgen receptor corepressors and prostate cancer
Endocr. Relat. Cancer, December 1, 2006; 13(4): 979 - 994.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Carascossa, J. Gobinet, V. Georget, A. Lucas, E. Badia, A. Castet, R. White, J.-C. Nicolas, V. Cavailles, and S. Jalaguier
Receptor-Interacting Protein 140 Is a Repressor of the Androgen Receptor Activity
Mol. Endocrinol., July 1, 2006; 20(7): 1506 - 1518.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Burd, C. E. Petre, L. M. Morey, Y. Wang, M. P. Revelo, C. A. Haiman, S. Lu, C. M. Fenoglio-Preiser, J. Li, E. S. Knudsen, et al.
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation
PNAS, February 14, 2006; 103(7): 2190 - 2195.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society